(Q43853392)

English

Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract

scientific article published on 12 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Wen-Lun Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Wei-Lun Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yi-Chun Yeh

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ching-Tai Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Chi-Yang Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jaw-Town Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bor-Shyang Sheu

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

12 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Molecular Carcinogenesis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

438-445

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Matrix metalloproteinases: regulators of the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix.

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

https://api.crossref.org/works/10.1002%2FMC.21874

21 January 2018

Identifiers

10.1002/MC.21874

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

release_nv33zo22fbejnft6rrebxq3sfu

1 reference

https://api.fatcat.wiki/v0/release/nv33zo22fbejnft6rrebxq3sfu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43853392&oldid=2103902486"